Bob Holtkamp, Director of Prevention & Outreach

Slides:



Advertisements
Similar presentations
9th Advanced HIV Course Aix-en-Provence 2011 Role of ARV as Prevention Martin Fisher Brighton and Sussex University Hospitals, UK.
Advertisements

PrEP: HIV Pre-exposure Prophylaxis Katherine Marx, MS, MPH, FNP-BC June 2014.
Dr. Carol Odula (Obs./Gyn.) May 7 th 2013 Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection.
Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection James Wilton Project Coordinator Biomedical Science of HIV Prevention
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
Potential role of PEP, PrEP and ART for HIV Prevention among Men who have Sex with Men Frits van Griensven, PhD, MPH Division of HIV/AIDS Prevention US.
New York State Department of Health AIDS Institute June, 2014
HIV Science Update: From Rome to Addis – Biomedical Prevention Elly T Katabira, FRCP Department of Medicine Makerere University College of Health Sciences.
N ORTHWEST AIDS E DUCATION AND T RAINING C ENTER PrEP 201: Beyond the Basics Joanne Stekler, MD MPH Associate Professor of Medicine University of Washington.
MSM 2003HIV positive 17 % 2005HIV positive 28 % 2007HIV positive 32 %
Looking back, looking forward: what we know and don’t know about oral PrEP and tenofovir gel for preventing HIV in women Jared Baeten MD PhD Departments.
Looking back, looking forward: what we know and don’t know about oral PrEP and tenofovir gel for preventing HIV in women Jared Baeten MD PhD Departments.
Michael Hughes, MD Assistant Clinical Professor UCR Eisenhower Medical Associates.
Pharmacist-Managed HIV Pre-Exposure Prophylaxis (PrEP) Clinic: Preliminary Outcomes From an Urban Community Health Clinic Mark T. Sawkin, PharmD, AAHIVP.
N ORTHWEST A IDS E DUCATION AND T RAINING C ENTER Pre-exposure Prophylaxis for HIV Prevention Efficacy and the importance of adherence Joanne Stekler,
A pill to prevent HIV? For women??
The Continuum of Participation in Research From HIV Prevention to Care: Seven Years of the iPrEx Trial Public Engagement with HIV Science.
Looking Ahead to MTN-017 Ross D. Cranston MD, FRCP Microbicide Trials Network IRMA.
HIV and Women Collaborating Across Borders to Advance the Health of Women IAS 2012 Gina M. Brown, M.D. July 22, 2012.
PrEP Facts Clinical trials have shown daily oral Tenofovir to effectively prevent HIV acquisition PrEP must only be prescribed for HIV- patients and patients.
HIV PRE-EXPOSURE PROPHYLAXIS (PREP) YUMA HEALTH DISTRICT 5/23/16 ALYSSA GUIDO, MPH PROGRAM DIRECTOR, ARIZONA AETC ARIZONA AIDS EDUCATION AND TRAINING CENTER.
Expanded PrEP implementation across Australia Expanded implementation of PrEP across Australia 1.
Pre-exposure Prophylaxis (PrEP) for HIV Prevention: What’s the Future? Joanne Stekler, MD MPH Assistant Professor of Medicine University of Washington.
PrEP Case Consultation
PrEP, medication to prevent HIV
Providing PrEP – The Basics
Tenvir-Em Online Tenvir-EM tablets are used as part of a regiment of antiretroviral medications to treat HIV-1 in adults over 18 years of age. Manufactured.
Pacific AIDS Education and Training Center
Information about HIV Prevention Options
PrEP for HIV Prevention
HIV Post Exposure Prophylaxis
Module 4 (e) Pregnancy and Breast Feeding
High level of retention and adherence at week 48 for MSM and TGW enrolled in the PrEP Brasil demonstration study Beatriz Grinsztejn, Brenda Hoagland, Ronaldo.
HIV Burden Among Gay and Bisexual Men in the U.S.
Preexposure Prophylaxis (PreP) for the Prevention of HIV
Module 4 (c) Stopping PrEP
A protocol in development IMPAACT Prevention Scientific Committee
On behalf of The MTN-020/ASPIRE Study Team
Pharmacokinetics: HIV Drugs
PrEP as an HIV Prevention Tool in Queer Communities of Color: Barriers and Opportunities BACKGROUND Joanne Stekler, MD MPH.
Tenvir-Em Tenvir EM is a generic version of Truvada and is used as part of a regiment of antiretroviral medications to treat HIV-1 in adults over 18. Each.
On Demand PrEP for Men at High Risk for HIV IPERGAY
Module 4 (a) Getting started on PrEP
Pharmacokinetics: HIV Drugs
Pre-exposure Prophylaxis (PrEP)
MTN-025 (HOPE Study) Community Education Presentation
PrEP: A Case-by-Case Approach
HIV and the ART of Prevention
Do Patients adherent on PrEP exposed to HIV have seroconversion symptoms & falsely reactive HIV tests? Mark Roche1, Elaney Youssef1, Yvonne Gilleece¹,
22th International AIDS Conference
Overview.
Phase 2 Treatment Naïve Injection Drug Use
PrEP Effectiveness. Preexposure Prophylaxis Translating the Clinical Trials Into Clinical Practice.
Prescribing PrEP to adolescents and young adults
Pre-Exposure Prophylaxis (PrEP) for HIV Infection
PrEP Pre-Exposure Prophylaxis
PrEP.
Initiating Pre-exposure Prophylaxis The PrEP Checklist
From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP
100 Partners PrEP[5] Efficacy 75% Adherence 81% 80
PrEP for HIV Prevention
HIV.
HIV nPEP* Process Algorithm - DRAFT
PrEP for HIV Prevention
National HIV notifications Q – Q4 2018
Lesson 3: Treatment as Prevention
U=U Guidance for Implementation in Clinical Settings
PrEP in Brazil: 18 months of implementation as a public health policy
Undetectable = Untransmittable
Presentation transcript:

Bob Holtkamp, Director of Prevention & Outreach 1636 S. Glenstone Springfield, MO 65804 417-881-1900 Bob Holtkamp, Director of Prevention & Outreach Bob.Holtkamp@APO-Ozarks.org

PrEP (Pre-Exposure Prophylaxis) PrEP is a method for people who are HIV-negative and at substantial risk for HIV infection Pill contains two anti-retroviral medicines which taken daily reduces risk of HIV infection by 95% . Effective after 7 days use for men and 21 days for women. Side effects such as an upset stomach or headache, but are mild and usually disappear within the first month.

iPrEx study 2,499 gay, bisexual, and other men who have sex with men in US, Peru, Thailand, Ecuador, and South Africa Average of 18 sexual partners in the last 3 months 60% reported condomless sex in the last 3 months 77.5% reported condomless sex with a partner of unknown HIV status in the last 6 months 2.5% reported condomless sex with a HIV-positive partner in the last 6 months

Reported Side Effects 2% Elevated Creatinine (Measure of kidney function) 2% Weight Loss 2% Nausea 4% Headache Monitor Kidney Function and bone mineral density www.healthline.com/health/truvada-prep-preventing-hiv-with-daily-pill-Infographic

IPrEx and Safety N Engl J Med 363;27 December 30, 2010 Adverse Event Drug (N = 1251) Placebo (N = 1248)   no. of patients (%) no. of events P Value* Any adverse event 867 (69) 2630 877 (70) 2611 0.50 Any serious adverse event 60 (5) 76 67 (5) 87 0.57 Any grade 3 or 4 event 151 (12) 248 164 (13) 285 0.51 Any grade 3 event 110 (9) 197 117 (9) 225 0.65 Any grade 4 event 41 (3) 51 47 (4) 60 Elevated creatinine level 25 (2) 28 14 (1) 15 0.08 Headache 56 (4) 66 55 0.10 Depression 43 (3) 46 62 (5) 63 0.07 Nausea 20 (2) 22 9 (<1) 10 0.04 Unintentional weight loss (≥5%) 27 (2) 34 19 Diarrhea 46 (4) 49 61 0.36 Bone facture 15 (1) 16 11 (<1) 12 0.41 Death 1 (<1)** 1 4 (<1) 4 0.18 Discontinuation of study drug Permanently 26 33 0.82 Permanently or Temporarily 79 (6) 99 72 (6) 92 0.49 * P values calculated by log rank test ** Death due to motorcycle accident N Engl J Med 363;27 December 30, 2010

iPrEx Results 44% reduction in HIV transmission among all participants 77% reduction among participants who reported that they were taking the drug 92% reduction among participants with detectable levels of drug in the blood 99% reduction among participants with levels of drug in the blood consistent with daily adherence

PrEP Dosing Doses/week Risk reduction (95%CI) 2 / week 76% 4 / week 96% 7 / week 99% Sci Transl Med. 2012 September 12; 4(15)

IPrEX and Behaviors Reported High risk behavior decreased substantially after enrollment and remained lower Counseling, testing, and dispensing condoms may have contributed to Safer behaviors Taking a pill a day may have served as a daily reminder of imminent risk and promoted planning for sex which has been associated with lower risk N Engl J Med 363;27 December 30, 2010

Uses of PrEP Serodiscordant couples (1 person with HIV and the other is not) Men who Sex with Men (MSM) Transgender persons Sex Workers/Transactional sex People who Inject Drugs (PWID) High-risk individuals-multiple partners/unknown status Individuals with multiple STIs in the previous year Mother-to-child prevention

CDC Recommendations Must be HIV-Negative Must be retested for HIV and STIs every 3 months Not intended to be used without condoms Creatine levels monitored

What PrEP not do? Does not protect a person against diseases like chlamydia, syphilis, herpes, or gonorrhea Does not prevent pregnancy Not a cure for HIV Doesn’t work as treatment for someone already living with HIV Doesn’t work if not taken consistently and correctly myprepexperience.blogspot.com

TRUVADA as PrEP Only Prescription medication approved (July 16, 2012) by the FDA for pre-exposure prophylaxis (PrEP) Fixed-dose anti-retroviral (combination of emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg) was originally approved in 2002 for treatment of HIV. Well known side effect profile. www.truvadapreprems.com/

Insurance Coverage for PrEP? ”We have not heard of any insurance company or any medicaid program outright denying coverage of truvada as PrEP. Some companies and programs are requiring prior-authorization, however, which requires paperwork to be filled out. And the type of insurance coverage you have, including prescription drug benefits, will determine the cost to you…” myprepexperience.blogspot.com

How to Pay: Insurance, Medicaid, Medicare Copay assistance from Gilead at 877-505-6986 and/or Patient Access Network at 866-316-PANF If Uninsured, free antiretroviral medicines through the Gilead at 855-330-5479 Resources: CDC.gov/hiv/pdf/prevention_PrEP_factsheet.pdf ProjectInform.org/prep PrEPFacts.org WhatisPrEP.org MyPrEPexperience.blogspot.com PrEPWatch.org Prep-faq.com

COPAY ASSISTANCE FOR TRUVADA if you have insurance Gilead HIV co-pay assistance coupon card You may be able to save on the co-pay for your TRUVADA prescription, with a GILEAD HIV co-pay coupon card. Visit www.Gileadcopay.com or call 1-877-505-6986 for more information and to see if you are eligible.* *Enrollees will have to answer a few questions to confirm eligibility, restrictions apply. The program is subject to change at any time.

www.prep-faq.com

WHY PrEP? Personal control to limit risk of HIV infection Once-a-day dose for all-day risk reduction Daily reminder to stay HIV negative

QUESTIONS?